Sodium zirconium cyclosilicate for treating hyperkalaemia (partial review of TA599) [ID6439]

Draft guidance

Draft consultation document (online commenting)

Draft guidance (downloadable version) (PDF 270 KB)

Equality impact assessment (downloadable version) (PDF 125 KB)

Committee papers (PDF 4.2 MB)

Final scope (PDF 141 KB)

Final stakeholder list (PDF 130 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 220 KB)

Draft matrix post referral (PDF 167 KB)